These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33392098)

  • 1. Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
    Wang Y; Liu Z; Shan F; Ying X; Zhang Y; Li S; Jia Y; Li Z; Ji J
    Front Oncol; 2020; 10():613988. PubMed ID: 33392098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?
    Chen Q; Mao R; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
    Cancer Med; 2020 Nov; 9(21):7849-7862. PubMed ID: 32886456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.
    Chen JB; Liu ZN; Wang YK; Shan F; Li SX; Jia YN; Xue K; Miao RL; Li ZM; Wu ZQ; Ying XJ; Zhang Y; Li ZY; Ji JF
    Front Oncol; 2022; 12():956706. PubMed ID: 36620591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?
    Liu Z; Wang Y; Shan F; Ying X; Zhang Y; Li S; Jia Y; Li Z; Ji J
    Cancer Manag Res; 2021; 13():147-161. PubMed ID: 33469359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment.
    Liu Z; Wang Y; Shan F; Ying X; Zhang Y; Li S; Jia Y; Miao R; Xue K; Li Z; Li Z; Ji J
    BMC Gastroenterol; 2021 Jul; 21(1):283. PubMed ID: 34246249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery.
    Wan XB; Zhang Q; Chen M; Liu Y; Zheng J; Lan P; He F
    Front Oncol; 2020; 10():1280. PubMed ID: 32974129
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs . chemotherapy alone in HER2(-) locally advanced gastric cancer: A propensity score-matched cohort study.
    Xu G; Liu T; Shen J; Guan Q
    Chin Med J (Engl); 2024 Feb; ():. PubMed ID: 38420853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The largest lymph node defined response to neoadjuvant chemotherapy can predict long-term prognosis in locally advanced gastric cancer.
    Liu L; Wang Y; Liu T; Rao S; Zeng M
    Abdom Radiol (NY); 2023 Dec; 48(12):3653-3660. PubMed ID: 37755476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval time between neoadjuvant chemotherapy and surgery in advanced gastric cancer doesn't affect outcome: A meta analysis.
    Zhai Y; Zheng Z; Deng W; Yin J; Bai Z; Liu X; Zhang J; Zhang Z
    Front Surg; 2022; 9():1047456. PubMed ID: 36726960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of short- and long-term outcomes between laparoscopic and open gastrectomy for locally advanced gastric cancer following neoadjuvant chemotherapy: a propensity score matching analysis.
    Zhong H; Liu X; Tian Y; Cao S; Li Z; Liu G; Sun Y; Zhang X; Han Z; Meng C; Jia Z; Wang Q; Zhou Y
    Surg Endosc; 2023 Aug; 37(8):5902-5915. PubMed ID: 37072637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study.
    Liu X; Zhao Y; Jiao X; Yu Y; Li R; Zeng S; Chi J; Ma G; Huo Y; Li M; Peng Z; Liu J; Zhou Q; Zou D; Wang L; Li Q; Wang J; Yao S; Chen Y; Ma D; Hu T; Gao Q
    J Ovarian Res; 2023 Jun; 16(1):121. PubMed ID: 37370087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis.
    Ling Q; Huang ST; Yu TH; Liu HL; Zhao LY; Chen XL; Liu K; Chen XZ; Yang K; Hu JK; Zhang WH
    World J Surg Oncol; 2023 Dec; 21(1):377. PubMed ID: 38037067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Interval between Neoadjuvant Chemotherapy and Gastrectomy on Pathological Response and Survival Outcomes for Patients with Locally Advanced Gastric Cancer: A Meta-analysis.
    Naveed S; Banday SZ; Qari H; Zahoor S; Batoo AJ; Wahid MA; Haq MFU
    Euroasian J Hepatogastroenterol; 2022; 12(2):81-91. PubMed ID: 36959991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis.
    Eom BW; Kim S; Kim JY; Yoon HM; Kim MJ; Nam BH; Kim YW; Park YI; Park SR; Ryu KW
    J Gastric Cancer; 2018 Mar; 18(1):69-81. PubMed ID: 29629222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy.
    Jiang Q; Zeng X; Zhang C; Yang M; Fan J; Mao G; Shen Q; Yin Y; Liu W; Tao K; Zhang P
    World J Surg Oncol; 2022 Aug; 20(1):261. PubMed ID: 35978363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early myelostimulation in patients with locally advanced gastric cancer after fluorouracil plus platinum-based neoadjuvant chemotherapy is related to poor prognosis.
    Liu Y; Cao Y; Xiao L; Wang H
    Cancer Chemother Pharmacol; 2021 May; 87(5):701-710. PubMed ID: 33611625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of laparoscopic gastrectomy for patients with locally advanced gastric cancer following neoadjuvant chemotherapy.
    Liu L; Wang C; Li F; Zhang X; Cheng X; Lin S; Liu Y; Yang C; Li W
    Sci Rep; 2022 Jun; 12(1):10384. PubMed ID: 35726012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival results of patients with locally advanced gastric cancer and pathological complete response after neoadjuvant chemotherapy and resection.
    Wang T; Wang N; Zhou H; Zhou A; Jin J; Chen Y; Zhao D
    Transl Cancer Res; 2020 Feb; 9(2):529-535. PubMed ID: 35117397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Time Interval from Neoadjuvant Chemotherapy to Surgery in Primary Ovarian, Tubal, and Peritoneal Cancer Patients.
    Chen M; Chen Z; Xu M; Liu D; Liu T; He M; Yao S
    J Cancer; 2018; 9(21):4087-4091. PubMed ID: 30410613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of tislelizumab plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for patients with locally advanced gastric cancer: real-world experience with a consecutive patient cohort.
    Jiang Q; Liu W; Zeng X; Zhang C; Du Y; Zeng L; Yin Y; Fan J; Yang M; Tao K; Zhang P
    Front Immunol; 2023; 14():1122121. PubMed ID: 37215127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.